Clover Health Investments (CLOV) Reports In-Line Q4 EPS ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $487.2 million versus the consensus estimate of $467.06 million.

GUIDANCE:

Clover Health Investments sees FY 2026 revenue of $2.81-2.92 billion, versus the consensus of $2.74 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Culp, Inc. (CULP) Misses Q4 EPS by 12c
• FDA approves Casgevy gene therapy for sickle cell in children 2+